Methylprednisolone sodium succinate and Encephalitis autoimmune - a phase IV clinical study of FDA data

Summary:

Encephalitis autoimmune is reported as a side effect among people who take Methylprednisolone sodium succinate (methylprednisolone sodium succinate), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Pantoprazole, and have Encephalopathy.

The phase IV clinical study analyzes which people have Encephalitis autoimmune when taking Methylprednisolone sodium succinate. It is created by eHealthMe based on reports of 18,153 people who have side effects when taking Methylprednisolone sodium succinate from the FDA, and is updated regularly.

What is Methylprednisolone sodium succinate?

Methylprednisolone sodium succinate has active ingredients of methylprednisolone sodium succinate. eHealthMe is studying from 18,163 Methylprednisolone sodium succinate users. Check the latest studies of Methylprednisolone sodium succinate.

What is Encephalitis autoimmune?

Encephalitis autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain) is found to be associated with 112 drugs and 146 conditions by eHealthMe. Check the latest studies of Encephalitis autoimmune.



On Jul, 26, 2026

18,153 people reported to have side effects when taking Methylprednisolone sodium succinate.
Among them, 11 people (0.06%) have Encephalitis autoimmune.

Could Methylprednisolone sodium succinate cause Encephalitis autoimmune?

Among these 11 people:

How long have people been on Methylprednisolone sodium succinate when they have Encephalitis autoimmune? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Encephalitis autoimmune when taking Methylprednisolone sodium succinate? *

  • female: 37.5 %
  • male: 62.5 %

What is the age of people who have Encephalitis autoimmune when taking Methylprednisolone sodium succinate? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 28.57 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 42.86 %
  • 60+: 28.57 %

What are other drugs people take besides Methylprednisolone sodium succinate? *

  1. Pantoprazole: 4 people, 36.36%
  2. Oxycodone: 3 people, 27.27%
  3. Tylenol: 3 people, 27.27%
  4. Benadryl: 3 people, 27.27%
  5. Zopiclone: 2 people, 18.18%
  6. Amlodipine: 2 people, 18.18%
  7. Calcium: 2 people, 18.18%
  8. Celebrex: 2 people, 18.18%
  9. Ergocalciferol: 2 people, 18.18%
  10. Escitalopram: 2 people, 18.18%

What are other side effects people have besides Encephalitis autoimmune? *

  1. Encephalitis (inflammation of the brain): 3 people, 27.27%
  2. White Blood Cells Urine Positive: 2 people, 18.18%
  3. Injection Site Extravasation (flow of (blood or lymph) from injection site): 2 people, 18.18%
  4. Aspartate Aminotransferase Increased: 2 people, 18.18%
  5. Blood Pressure Diastolic Abnormal: 2 people, 18.18%
  6. Blood Pressure Diastolic Increased: 2 people, 18.18%
  7. Blood Pressure Systolic Abnormal: 2 people, 18.18%
  8. Blood Pressure Systolic Increased: 2 people, 18.18%
  9. Canker Sores (painful, open sore in the mouth): 2 people, 18.18%
  10. Disease Recurrence: 2 people, 18.18%

What are the existing conditions these people have? *

  1. Tumor Pain: 2 people, 18.18%
  2. Stress And Anxiety: 2 people, 18.18%
  3. Agitation (state of anxiety or nervous excitement): 2 people, 18.18%
  4. Back Pain: 2 people, 18.18%
  5. Constipation: 2 people, 18.18%
  6. Csf Collection: 2 people, 18.18%
  7. Depression: 2 people, 18.18%
  8. Diabetes: 2 people, 18.18%
  9. Encephalitis (inflammation of the brain): 2 people, 18.18%
  10. Encephalopathy (functioning of the brain is affected by some agent or condition): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone sodium succinate and have Encephalitis autoimmune?

- Check whether Encephalitis autoimmune is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone sodium succinate:

Encephalitis autoimmune treatments and more:

How severe was Encephalitis autoimmune and when was it recovered:

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylprednisolone sodium succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalitis autoimmune:

Browse all the conditions that are associated with Encephalitis autoimmune:


How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Methylprednisolone sodium succinate) and Methylprednisolone sodium succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: